Product news

Share this article:
Novo Nordisk AS and Sciele Pharma Inc. announced on Wednesday the launch of a type 2 diabetes combination drug. PrandiMet combines Novo Nordisk's Prandin (repaglinide) with the generic drug metformin.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions